Analysts Issue Forecasts for Gilead Sciences Q2 Earnings
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Zacks Research increased their Q2 2025 EPS estimates for Gilead Sciences in a research report issued on Thursday, May 8th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will earn $1.93 per share for the quarter, up from their previous forecast […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Zacks Research increased their Q2 2025 EPS estimates for Gilead Sciences in a research report issued on Thursday, May 8th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will earn $1.93 per share for the quarter, up from their previous forecast […]
